| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |